Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
about
A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies.The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophyModifier genes and their effect on Duchenne muscular dystrophyGenetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations.Homozygous nonsense mutation in SGCA is a common cause of limb-girdle muscular dystrophy in Assiut, Egypt.LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11.Distinct genetic regions modify specific muscle groups in muscular dystrophy.Phenotypic and immunohistochemical characterization of sarcoglycanopathies.A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 familiesMolecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamsterReengineering a transmembrane protein to treat muscular dystrophy using exon skippingModifying muscular dystrophy through transforming growth factor-β.Neuromuscular disorders: genes, genetic counseling and therapeutic trialsLatent TGF-beta-binding protein 4 modifies muscular dystrophy in mice.Carrier frequency of the c.525delT mutation in the SGCG gene and estimated prevalence of limb girdle muscular dystrophy type 2C among the Moroccan population.Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair.Modifiers of heart and muscle function: where genetics meets physiology.Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds.Nesprin-1 mutations in human and murine cardiomyopathy.Stem cells from umbilical cord blood do have myogenic potential, with and without differentiation induction in vitroEngineered electrical conduction tract restores conduction in complete heart block: from in vitro to in vivo proof of concept.The superhealing MRL background improves muscular dystrophy.Interplay between heart and skeletal muscle disease in heart failure: the 2011 George E. Brown Memorial Lecture.A slowly progressive form of limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican Hispanics.Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy.Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease.Humanizing the mdx mouse model of DMD: the long and the short of it.Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers.
P2860
Q24517965-41491F61-E9AC-4234-954B-9B7AA58347C4Q24678868-F8D81A00-62AC-46ED-9A71-F72613AF25F4Q26827638-5DB214AE-1078-4CE7-A80E-D93FE5BC6262Q28083441-0E42D311-D126-463D-8E12-E7CACE546A05Q33679819-A169FED4-DE50-45C1-B4E4-89A3056114F5Q33751724-953C95C8-D9B7-4D1E-8E82-13A849ED2C9AQ33931637-453602A8-C80B-4D3D-80E2-EBB51F065F29Q34389112-4A5EA378-0D17-41A0-8A2E-21144EE80BBBQ34518008-DA8FC34F-0F83-4C0F-8C17-4785AEC721B8Q35232488-49749AA0-5BD8-4809-9ED4-DBE37DD4D3ABQ35434715-28D31DD8-0D28-447B-BD83-1E587EA66B82Q35754551-7334BC86-16D3-46DB-81DF-A8D2E00224DFQ36266510-B608DF9C-9A24-4407-A396-7EC8BBB77146Q37064241-397D18A4-ED9C-4ADB-939C-CA4F8DC4C597Q37217303-2D2D7A31-DDA9-46AD-8E38-6DCCF769124FQ37452338-2011DE09-97EF-4B21-A3D0-D443A2BC82E5Q37687779-714FCDFB-0DA7-477B-BA1F-73067B860A23Q37725303-BD302B0D-122D-48B2-AAAC-70A6D6D3858BQ38161422-DB0FB69A-EFB4-4542-B391-58161477135FQ38615889-6B7D1D0A-DFE9-4B94-8F8F-95956B84D272Q39599077-2D149143-8676-48DA-93AC-26EC0F554B8BQ40010250-28C0E62C-3445-4095-9951-10A5579CA927Q41938602-14E92CCF-8040-4DF8-AFA2-464C9BF577F5Q42489265-FDB07434-1D90-4836-84DC-8164481DA6D4Q42580068-356984FE-0605-49F7-8E53-E00FB7CF608CQ42728199-8B1A928D-D2AB-4786-BA53-3ADB40983C2EQ47561363-A1CB469D-6B02-44D1-9E5B-9041AC5B3E40Q51480634-A6A1BC98-1C88-4671-8A6A-67F808E27758Q55010648-78269098-F4EE-4846-906A-D36B58016170Q55496176-2D713B1E-2BEC-444A-A747-7BE26D650AF1
P2860
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@ast
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@en
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@nl
type
label
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@ast
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@en
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@nl
prefLabel
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@ast
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@en
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@nl
P2093
P2860
P3181
P1476
Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation
@en
P2093
C G Bönnemann
E M McNally
E de Sá Moreira
K B Othmane
L M Kunkel
M R Passos-Bueno
P H Denton
P2860
P304
P3181
P407
P50
P577
1996-11-01T00:00:00Z